ข่าวประชาสัมพันธ์ rheumatoid arthritis+lifestyle

"Rhom Bho Property" (TITLE) Builds on Success, Expands in Strategic Locations with New Condominium Project "Adora Rawai" Worth THB 1.4 Billion, Meeting High Demand in Phuket's Hotspot Rawai Beach

Rhom Bho Property Public Company Limited, also known as "TITLE," continues to build on its success by launching a new condominium project, "Adora Rawai," under the concept "Adorable lifestyle beside the Ocean." Strategically located near Rawai Beach, this THB 1.4 billion development is designed to attract homeowners, investors, and international buyers. It features meticulous design and extensive shared spaces, including both outdoor and indoor amenities across three levels, offering up to 27

"ร่มโพธิ์ พร็อพเพอร์ตี้" (TITLE) สานต่อคว... "ร่มโพธิ์ พร็อพเพอร์ตี้" (TITLE) สานต่อความสำเร็จ รุก Strategic Location ต่อเนื่อง — "ร่มโพธิ์ พร็อพเพอร์ตี้" (TITLE) สานต่อความสำเร็จ รุก Strategic Locat...

A new chapter is unfolding on the shores ... THAILAND BEACH TEQBALL OPEN 2025 MARKS THE RISE OF SICHON AS THAILAND'S NEXT GREAT COASTAL DESTINATION — A new chapter is unfolding on the shores of Sicho...

Kimpton Maa-Lai Bangkok, the Langsuan lux... KIMPTON MAA-LAI BANGKOK HOSTS AN INDULGENT BRUNCH AND FUN EASTER EGG HUNT THIS EASTER SUNDAY — Kimpton Maa-Lai Bangkok, the Langsuan luxury and lifestyle ...

MR. D.I.Y. has solidified its position as... MR. D.I.Y. Wins Two Awards at the "2025 Thailand's Most Admired Brand" for the Second Consecutive Year — MR. D.I.Y. has solidified its position as the lea...

Menarini Asia-Pacific Enters into an Exclusive Licensing Agreement with Astellas to Commercialize Smyraf(R) in Taiwan and select South-East Asian markets

Menarini Asia-Pacific has entered into a long-term exclusive licensing partnership with Astellas Pharma Inc. (Astellas) for the development,...

Tennis Champion Caroline Wozniacki and UCB Launch Advantage Hers Campaign for Women with Chronic Inflammatory Diseases

- Grand Slam winner Caroline Wozniacki is the highest-ranking female athlete known to have been diagnosed with rheumatoid arthritis whilst still playing professional tennis -...

Zydus Launches World’s First Biosimilar of Adalimumab

Access to this therapy will impact 12 million people suffering from auto immune disorders like rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, and Ankylosing Spondylitis in India After more than a decade-long wait, the...

Coherus Announces Initiation Of Phase 3 Trial Of CHS-0214 (Investigational Etanercept Biosimilar) In Chronic Plaque Psoriasis (RaPsOdy)

Company Advances Development as Part of Collaboration with Baxter International's Biopharmaceutical Business Coherus BioSciences, Inc. announced the start of its...

Coherus Announces Initiation Of Phase 3 Trial Of CHS-0214 (Investigational Etanercept Biosimilar) In Rheumatoid Arthritis

Coherus Advances Development as Part of Collaboration with Daiichi Sankyo and Baxter Coherus BioSciences, Inc. announced the start of its Phase 3 trial of CHS-0214, an...

Yok Chinese Restaurant of the Emerald Hot... “Marinated shredded chicken with jelly fish served cold” @ Yok Chinese Restaurant — Yok Chinese Restaurant of the Emerald Hotel would like to invite you t...

Data Published Today Reveal That Novel Oral Therapy Fostamatinib Demonstrates Positive Response in Rheumatoid Arthritis Patients

- Phase II Study Published in the New England Journal of Medicine AstraZeneca's (LSE: AZN) new oral syk inhibitor, fostamatinib (R788), recently in-licensed from Rigel...

Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas

- Results From a Survey Conducted by UCB Assessing the Lifestyles of Women With Rheumatoid Arthritis in Seven Major Industrialized Countries - A third of women living with rheumatoid arthritis say their disease impacts their enjoyment of...

Asian Countries Cannot Afford To Ignore the Cost of Rheumatoid Arthritis

- Early Diagnosis and Treatment for Patients with Rheumatoid Arthritis Urgently Needed to Relieve Social, Economic and Personal Disease Burden - - New Initiative Launched to Highlight the Need to Reassess Treatment Approaches in...

ฮูไมร่า (HUMIRA)(R) (adalimumab) ของแอ๊บบอตได้รับการยกย่องจากรางวัล กาเลน ไพรซ์ว่า เป็นนวัตกรรมในการรักษาผู้ป่วย

พริกซ์ กาเลียน จากสหรัฐอเมริกา ยกย่องให้ฮูไมร่าเป็นสินค้าเทคโนโลยีชีวภาพที่ดีที่สุด แอ๊บบอต (NYSE: ABT) ผู้นำในการรักษาโรคเกี่ยวกับภูมิคุ้มกันอัตโนมัติ ได้รับรางวัลกาเลน ไพรซ์ ปี 2007 ...

Abbott's HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care

Prix Galien USA Names HUMIRA Best Biotechnology Product Abbott (NYSE: ABT), a leader in the treatment of autoimmune diseases, has received the 2007 Galen Prize for Best Biotechnology Product for HUMIRA...

Actemra: Roche's Novel Rheumatoid Arthritis Drug Shows Substantial Benefits for Patients in OPTION Study

New Data Supports IL-6 Receptor Inhibition as a Key Component in Controlling Inflammation From RA Roche today announced significant results from 'OPTION'(1), the first rheumatoid arthritis...

Latest Data Show MabThera(R) Provides Significant and Sustained Relief From Signs and Symptoms of Rheumatoid Arthritis

Patients Experience Consistent Safety Profile With Subsequent Courses of Therapy New data presented at the EULAR meeting (European League Against Rheumatism) demonstrate that...